Key Takeaways
- Biotalys announces significant changes to its board and management team, reducing board members from eight to six.
- CEO Kevin Helash and Chief Business Development Officer Kamal El Mernissi resign effective immediately and March 31, 2026, respectively.
- Carlo Boutton will serve as interim CEO, with Patrik Haesen appointed as Chair of the Audit Committee.
Leadership Transition at Biotalys
Biotalys, a Belgium-based AgTech firm focused on sustainable crop protection, has announced key changes within its leadership structure. Effective immediately, the company will downsize its Board of Directors from eight members to six, while the Executive Committee will also reduce from four to two members.
Laura Meyer, a board member who has held the position of Chair of the Audit Committee since September 2024, will step down immediately. In addition, Kevin Helash, who took on the role of CEO in October 2023, will also leave the company now. Chief Business Development Officer Kamal El Mernissi will depart the organization effective March 31, 2026.
In light of these departures, Carlo Boutton, currently serving as Chief Scientific Officer, will step in as interim CEO. Meanwhile, Patrik Haesen has been appointed by the board as the new Chair of the Audit Committee.
Simon Moroney, Chairman of the Board, commented, “These leadership changes mark the beginning of a new chapter for Biotalys. On behalf of the board and the entire organization, I would like to thank Laura, Kevin, and Kamal for their service. We wish them continued success in their future endeavors.”
These leadership shifts aim to steer Biotalys into a new direction as the company continues to develop protein-based biocontrol solutions that prioritize sustainability in agriculture. With the recent changes, Biotalys is positioned to adapt and innovate in a rapidly evolving industry landscape.
The content above is a summary. For more details, see the source article.
